ID

23048

Description

Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine; ODM derived from: https://clinicaltrials.gov/show/NCT00511095

Lien

https://clinicaltrials.gov/show/NCT00511095

Mots-clés

  1. 21/06/2017 21/06/2017 -
Téléchargé le

21 juin 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hepatitis B NCT00511095

Eligibility Hepatitis B NCT00511095

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
willing and able to give written informed consent
Description

ID.1

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
women of childbearing potential must be willing to consistently use a highly effective method of birth control
Description

ID.2

Type de données

boolean

Alias
UMLS CUI [1]
C0009862
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
women who are pregnant or breastfeeding
Description

ID.3

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
any previous hbv infection
Description

ID.4

Type de données

boolean

Alias
UMLS CUI [1]
C0019169
previous vaccination (1 or more doses) with any hbv vaccine
Description

ID.5

Type de données

boolean

Alias
UMLS CUI [1]
C0474232
any previous autoimmune diseases
Description

ID.6

Type de données

boolean

Alias
UMLS CUI [1]
C0004364
are at high risk for recent exposure to hbv, hepatitis c virus (hcv) or human immunodeficiency virus (hiv)
Description

ID.7

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332167
UMLS CUI [1,2]
C0019163
UMLS CUI [1,3]
C0220847
UMLS CUI [1,4]
C0019682
received any blood products or antibodies within 3 months prior to study entry
Description

ID.8

Type de données

boolean

Alias
UMLS CUI [1,1]
C0456388
UMLS CUI [1,2]
C0003241
ever received an injection with dna plasmids or oligonucleotides
Description

ID.9

Type de données

boolean

Alias
UMLS CUI [1,1]
C4086231
UMLS CUI [1,2]
C0028953
received any vaccines within 4 weeks prior to study entry
Description

ID.10

Type de données

boolean

Alias
UMLS CUI [1]
C0042210
received any other investigational medicinal agent within 4 weeks prior to study entry
Description

ID.11

Type de données

boolean

Alias
UMLS CUI [1]
C0013230

Similar models

Eligibility Hepatitis B NCT00511095

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
willing and able to give written informed consent
boolean
C0021430 (UMLS CUI [1])
ID.2
Item
women of childbearing potential must be willing to consistently use a highly effective method of birth control
boolean
C0009862 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.3
Item
women who are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
ID.4
Item
any previous hbv infection
boolean
C0019169 (UMLS CUI [1])
ID.5
Item
previous vaccination (1 or more doses) with any hbv vaccine
boolean
C0474232 (UMLS CUI [1])
ID.6
Item
any previous autoimmune diseases
boolean
C0004364 (UMLS CUI [1])
ID.7
Item
are at high risk for recent exposure to hbv, hepatitis c virus (hcv) or human immunodeficiency virus (hiv)
boolean
C0332167 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0220847 (UMLS CUI [1,3])
C0019682 (UMLS CUI [1,4])
ID.8
Item
received any blood products or antibodies within 3 months prior to study entry
boolean
C0456388 (UMLS CUI [1,1])
C0003241 (UMLS CUI [1,2])
ID.9
Item
ever received an injection with dna plasmids or oligonucleotides
boolean
C4086231 (UMLS CUI [1,1])
C0028953 (UMLS CUI [1,2])
ID.10
Item
received any vaccines within 4 weeks prior to study entry
boolean
C0042210 (UMLS CUI [1])
ID.11
Item
received any other investigational medicinal agent within 4 weeks prior to study entry
boolean
C0013230 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial